Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
Completed
Conditions studied: Glioblastoma Multiforme, Healthy Volunteers
In brief
The purpose of this study is to determine if tumor cells can be detected in the blood of patients diagnosed with a brain tumor.
Key facts
- Study ID
- NCT01135875
- Run by
- University of Florida
- People needed
- 130
- Starts
- 2009-10-01
- Expected to finish
- 2013-04-01
- Last updated by the study team
- 2013-10-17
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 18 to 89 years of age
- Weight of at least 110 pounds
- Able to provide informed consent for self
You may not qualify if…
- Patients with active malignant tumors other than GBM
Where it is running
- University of Florida — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.